Mass. Medicaid Leukotriene Blocker Limitation Seeks To Curb Allergy Use
Executive Summary
Oral leukotriene blocker prescriptions will require prior authorization in the Massachusetts Medicaid program in an effort to curb use of the products for allergic rhinitis